Learn More
Medchemexpress LLC Solangepras | 2254706-21-1 | 99.7% | C24H29F2N5O3 | 10MG

Supplier: Medchemexpress LLC HY134661A10MG
Solangepras (CVN424) is an orally active, brain-penetrant inverse agonist of the orphan G protein-coupled receptor GPR6, developed for preclinical Parkinson's disease research. It exhibits high binding affinity and potent functional activity in cellular assays and is supplied as a solid research compound for laboratory studies.
- Orally active and brain-penetrant small molecule suitable for in vivo studies.
- High affinity GPR6 inverse agonist (Ki ≈ 9.4 nM).
- Potent functional activity (EC50 ≈ 38 nM) in relevant assays.
- Available as a stable solid for bench storage and formulation.
- Provided at high chemical purity for research use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.